Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology.
Sarah B JosephSara GianellaTricia H BurdoPaola CinqueMagnus GisslenScott LetendreAvindra NathSusan MorgelloLishomwa C NdhlovuSerena SpudichPublished in: The Journal of infectious diseases (2023)
Despite viral suppression with antiretroviral therapy (ART), people with human immunodeficiency virus (HIV) continue to experience central nervous system (CNS) complications, primarily in the form of mild cognitive impairment and mental health disorders (eg, depression, anxiety, other neuropsychiatric problems). The multifactorial pathogenesis and heterogeneity of mechanisms likely underlying CNS complications must be addressed in the development of preventive interventions and effective treatments. The biotyping approach has previously been useful to define phenotypes of other CNS diseases based on underlying mechanisms and could be translated to the field of neuroHIV. The purpose of the Biotype Workshop series, and the Virology, Immunology and Neuropathology Working Group in particular, is to capitalize on current and new technologies and guide future research efforts using the wealth of available immunological, virologic, and neuropathological data collected from people with HIV on and off ART.
Keyphrases
- antiretroviral therapy
- human immunodeficiency virus
- hiv infected
- mild cognitive impairment
- mental health
- hiv positive
- hiv infected patients
- hiv aids
- cognitive decline
- blood brain barrier
- risk factors
- sleep quality
- physical activity
- sars cov
- cerebrospinal fluid
- depressive symptoms
- mental illness
- hiv testing
- men who have sex with men
- electronic health record
- big data
- south africa
- artificial intelligence